← Evidence map

ReviewCurrent neurology and neuroscience reports2012

Botulinum toxin for the treatment of movement disorders.

Mary Ann Thenganatt et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it

The trial

NCT03508882phase 4100 enrolled2015
Full record →Abstract, authors, funding and every citing paper · PMID 22661378